X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
19
PharmaCompass offers a list of Potassium Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Potassium Citrate manufacturer or Potassium Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Potassium Citrate manufacturer or Potassium Citrate supplier.
PharmaCompass also assists you with knowing the Potassium Citrate API Price utilized in the formulation of products. Potassium Citrate API Price is not always fixed or binding as the Potassium Citrate Price is obtained through a variety of data sources. The Potassium Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ACALKA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ACALKA, including repackagers and relabelers. The FDA regulates ACALKA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ACALKA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ACALKA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ACALKA supplier is an individual or a company that provides ACALKA active pharmaceutical ingredient (API) or ACALKA finished formulations upon request. The ACALKA suppliers may include ACALKA API manufacturers, exporters, distributors and traders.
click here to find a list of ACALKA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ACALKA DMF (Drug Master File) is a document detailing the whole manufacturing process of ACALKA active pharmaceutical ingredient (API) in detail. Different forms of ACALKA DMFs exist exist since differing nations have different regulations, such as ACALKA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ACALKA DMF submitted to regulatory agencies in the US is known as a USDMF. ACALKA USDMF includes data on ACALKA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ACALKA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ACALKA suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The ACALKA Drug Master File in Japan (ACALKA JDMF) empowers ACALKA API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the ACALKA JDMF during the approval evaluation for pharmaceutical products. At the time of ACALKA JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of ACALKA suppliers with JDMF on PharmaCompass.
A ACALKA CEP of the European Pharmacopoeia monograph is often referred to as a ACALKA Certificate of Suitability (COS). The purpose of a ACALKA CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of ACALKA EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of ACALKA to their clients by showing that a ACALKA CEP has been issued for it. The manufacturer submits a ACALKA CEP (COS) as part of the market authorization procedure, and it takes on the role of a ACALKA CEP holder for the record. Additionally, the data presented in the ACALKA CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the ACALKA DMF.
A ACALKA CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. ACALKA CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of ACALKA suppliers with CEP (COS) on PharmaCompass.
A ACALKA written confirmation (ACALKA WC) is an official document issued by a regulatory agency to a ACALKA manufacturer, verifying that the manufacturing facility of a ACALKA active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting ACALKA APIs or ACALKA finished pharmaceutical products to another nation, regulatory agencies frequently require a ACALKA WC (written confirmation) as part of the regulatory process.
click here to find a list of ACALKA suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ACALKA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ACALKA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ACALKA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ACALKA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ACALKA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ACALKA suppliers with NDC on PharmaCompass.
ACALKA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ACALKA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ACALKA GMP manufacturer or ACALKA GMP API supplier for your needs.
A ACALKA CoA (Certificate of Analysis) is a formal document that attests to ACALKA's compliance with ACALKA specifications and serves as a tool for batch-level quality control.
ACALKA CoA mostly includes findings from lab analyses of a specific batch. For each ACALKA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ACALKA may be tested according to a variety of international standards, such as European Pharmacopoeia (ACALKA EP), ACALKA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ACALKA USP).
Market Place
